Novel Coronavirus (SARS-CoV-2/COVID-19)
Join the American Hospital Association September 14-16 for a virtual event brought to you by the AHA Center for Health Innovation and the Society for Health Care Strategy and Market Development that will convene the field’s leading thinkers, strategists and doers – including innovators who are…
Listen to the webinar
View the presentation slides.
Geisinger Health System in Danville, Pa., has partnered with Charlotte, N.C.-based Stanson Health, a Premier Inc. company, to develop an artificial intelligence-enabled solution for tracking COVID-19 transmission. The EHR-agnostic, free, real-time surveillance app sifts through volumes of…
Rogers Behavioral Health offers free resources on compassion, compassion fatigue, wellness and resilience strategies and other topics.
Suburban Hospital in Bethesda, Maryland, offers a Senior Shape exercise program via Zoom, so older adults keep moving and stay connected to others.
Dear Secretary Mnuchin and Chairman Powell:
Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and patients through the remainder of the public health emergency, the Centers for Medicare & Medicaid Services announced Friday.
FDA issues guidance on removed COVID-19 antibody tests; reporting potential medical device shortages
Clinical laboratories and health care providers should stop using any antibody tests on the Food and Drug Administration’s “removed” test list, evaluate prior results from the test and whether to retest the patient using an FDA-authorized test, the agency said.
CDC: Emergency department visits for life-threatening conditions declined in pandemic’s early months
A new study released by the Centers for Disease Control and Prevention shows emergency department visits dropped by 23% for heart attacks, 20% for strokes and 10% for hyperglycemic crises in first 10 weeks after the COVID-19 public health emergency declaration.
A study of the first 20,000 adults hospitalized with severe or life-threatening COVID-19 to receive convalescent plasma found the investigational therapy safe in this diverse group of patients, according to findings from the Food and Drug Administration’s Expanded Access Program for COVID-19…